Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats

Adamec, 1990, Does kindling model anything clinically relevant?, Biol. Psychiat., 27, 249, 10.1016/0006-3223(90)90001-I Avoli, 1991, Excitatory amino acid receptors in the human epileptogenic neocortex, Epilepsy Res., 10, 33, 10.1016/0920-1211(91)90092-T Bowyer, 1981, The effects of various anesthetics on amygdaloid kindled seizures, Neuropharmacology, 20, 199, 10.1016/0028-3908(81)90123-4 Callaghan, 1980, Pharmaceutical modification of amygdaloid-kindled seizures, Neuropharmacology, 19, 1131, 10.1016/0028-3908(80)90113-6 Chapman, 1987, Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((±)-2-carboxypiperazin-4-yl)propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonist, Eur. J. Pharmacol., 139, 91, 10.1016/0014-2999(87)90501-2 Chapman, 1990, Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice, Eur. J. Pharmacol., 178, 97, 10.1016/0014-2999(90)94798-3 Chapman, 1991, Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio-papio, Epilepsia, 32, 578, 10.1111/j.1528-1157.1991.tb04695.x Cotterell, 1992, Weak anticonvulsant activity of CGP-37849 and CGP-39551 against kindled seizures following systematic administration, Eur. J. Pharmacol, 214, 285, 10.1016/0014-2999(92)90132-N Croucher, 1992, Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds, Neurochem. Res., 17, 409, 10.1007/BF00969885 De Sarro, 1992, Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats, Eur. J. Pharmacol., 215, 221, 10.1016/0014-2999(92)90031-X Dziki, 1992, Kindled rats are more sensitive to the behavioural effects of combined treatment with MK-801 and valproate than non-kindled rats, Eur. J. Pharmacol., 222, 273, 10.1016/0014-2999(92)90866-3 Fagg, 1985, NMDA receptors: characterization of receptor binding sites and their association with the postsynaptic membrane, 45 Javitt, 1991, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiat., 148, 1301, 10.1176/ajp.148.10.1301 Löscher, 1985, Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the Mongolian gerbil, J. Pharmacol. Exp. Ther., 233, 204 Löscher, 1993, Effect of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain, Neurochem. Res., 18, 485, 10.1007/BF00967253 Löscher, 1990, High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats, Naunyn-Schmiedeb. Arch. Pharmacol., 341, 476, 10.1007/BF00176343 Löscher, 1991, Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine, J. Pharmacol. Exp. Ther., 256, 432 Löscher, 1991, The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: Attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors, J. Pharmacol. Exp. Ther., 257, 1146 Löscher, 1991, Responses to NMDA receptor antagonists altered by epileptogenesis, Trends Pharmacol. Sci., 12, 52, 10.1016/0165-6147(91)90496-F Löscher, 1988, Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations, Epilepsy Res., 2, 145, 10.1016/0920-1211(88)90054-X Löscher, 1986, Is amygdala kindling in rats a model for drug-resistant partial epilepsy?, Exp. Neurol., 93, 211, 10.1016/0014-4886(86)90160-3 Löscher, 1988, Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital, Eur. J. Pharmacol., 152, 9, 10.1016/0014-2999(88)90830-8 Löscher, 1991, The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats, Neurosci. Lett., 128, 191, 10.1016/0304-3940(91)90258-U Löscher, 1991, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models, Epilepsy Res., 8, 79, 10.1016/0920-1211(91)90075-Q Marescaux, 1992, Genetic absence epilipsy in rats from Strasbourg — A review, 37 Martin, 1992, Kindling enhances sensitivity of CA3 hippocampal pyramidal cells to NMDA, J. Neurosci., 12, 1928, 10.1523/JNEUROSCI.12-05-01928.1992 Masukawa, 1991, NMDA receptor activation during epileptiform responses in the dentate gyrus of epileptic patients, Brain Res., 562, 176, 10.1016/0006-8993(91)91205-F Mcdonald, 1991, Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy, Ann. Neurol., 29, 529, 10.1002/ana.410290513 McLean, 1992, Effect of anticonvulsant drugs on responses of mouse central neurons in cell culture to NMDA, Polish J. Pharmacol. Pharm., 44, 46 McNamara, 1988, Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models, Neuropharmacology, 27, 563, 10.1016/0028-3908(88)90176-1 Meldrum, 1992, Excitatory amino acids in epilepsy and potential novel therapies, Epilepsy Res., 12, 189, 10.1016/0920-1211(92)90040-Z Mody, 1987, NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling, Nature, 326, 701, 10.1038/326701a0 Mori, 1992, Important roles of N-methyl-D-aspartate receptors in expression of amygdaloid-kindled seizure demonstrated by intraperitoneal administration of L-aspartate in dimethyl sulfoxide, Epilepsia, 33, 583, 10.1111/j.1528-1157.1992.tb02333.x Potter, 1992, New antiepileptic drugs: from serendipity to rational discovery, Epilepsia, 33, S1 Porter, 1986, Evaluation in man, 49 Pumain, 1992, Responses to N-methyl-D-aspartate are enhanced in rats with petit-mal-like seizures, 97 Racine, 1972, Modification of seizure activity by electrical stimulation: II. Motor seizure, Electroencephalogr. Clin. Neurophysiol., 32, 295, 10.1016/0013-4694(72)90178-2 Rogawski, 1990, Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev., 42, 223 Sato, 1990, Kindling: basic mechanisms and clinical validity, Electroencephalogr. Clin. Neurophysiol., 76, 459, 10.1016/0013-4694(90)90099-6 Schmidt, 1986, Clinical development of benzodiazepines and other antiepileptic drugs for intractable epilepsy, 219 Schmutz, 1990, The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents, Naunyn-Schmiedeb. Arch. Pharmacol., 342, 61, 10.1007/BF00178973 Squires, 1991, A review of evidence for GABAergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of ‘functional’ psychosis, Neurochem. Res., 16, 1099, 10.1007/BF00966587 Trimble, 1991, Epilepsy and behaviour, Epilepsy Res., 10, 71, 10.1016/0920-1211(91)90097-Y Turski, 1987, Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents, Neurosci. Lett., 73, 143, 10.1016/0304-3940(87)90008-5 Urbanska, 1991, Influence of MK-801 on the anticonvulsant activity of antiepileptics, Eur. J. Pharmacol., 200, 277, 10.1016/0014-2999(91)90582-B Wamil, 1991, Effect of anticonvulsant medications on responses to NMDA by mouse central neurons in cell culture, Epilepsia, 32, 14 Whitton, 1992, MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo, J. Neurochem., 58, 1573, 10.1111/j.1471-4159.1992.tb11381.x Willetts, 1990, The behavioral pharmacology of NMDA receptor antagonists, Trends Pharmacol. Sci., 11, 423, 10.1016/0165-6147(90)90150-7 Wong, 1986, The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist, 83, 7104 Zeise, 1991, Valproate supresses N-methyl-D-aspartate-evoked transient depolarizations in the rat neocortex in vitro, Brain Res., 544, 345, 10.1016/0006-8993(91)90078-A